GGrantIndex
Sort

51,593 grants matching hepatitis

Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)

$3,317,479
Kenneth E Palmer · University Of Louisville · U19 · FY2015 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$3,316,612
Barry Coller · Rockefeller University · UL1 · FY2010 · RR

University of Pennsylvania HIV Clinical Trials Unit

$3,313,023
Ian Frank · University Of Pennsylvania · UM1 · FY2022 · AI

Washington Metropolitan Women's Interagency HIV Study

$3,305,883
Mary A Young · Georgetown University · U01 · FY2011 · AI

CPCRA Clinical Trials Unit

$3,304,724
Fred M Gordin · George Washington University · U01 · FY2010 · AI

Epidemiology and Natural History of Cancer-Associated Viruses

$3,301,455
Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

SF Bay Area MACS/WIHS Combined Cohort Study

$3,300,000
Phyllis C Tien · University Of California, San Francisco · U01 · FY2019 · HL

Optimization of Fetal Hemoglobin Production to Prevent or Reverse Organ Damage and Improve Survival in Patients with Sickle Cell Disease

$3,298,666
Courtney Fitzhugh · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,297,742
Alan M Fogelman · University Of California Los Angeles · P01 · FY2013 · HL

PHRU-Setshaba Clinical Trials Unit

$3,297,099
Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2022 · AI

Mechanisms and biological consequences of the nuclear receptor CAR activation

$3,293,801
Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

DCTD Human Toxicology and Pharmacology

$3,290,376
Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA

Chemistry Services for the National Toxicology Program (General Chemistry Support)

$3,289,034
Reshan Fernando · Research Triangle Institute · N01 · FY2022 · ES

Washington Women's Interagency HIV/AIDS Study

$3,288,382
Seble G Kassaye · Georgetown University · U01 · FY2018 · AI

CPCRA Clinical Trials Unit

$3,264,706
Fred M Gordin · George Washington University · U01 · FY2009 · AI

GENERAL CLINICAL RESEARCH CENTER

$3,263,457
Charles Ginsburg · Ut Southwestern Medical Center · M01 · FY2006 · RR

Developmental Core

$3,262,258
Paul A. Goepfert · University Of Alabama At Birmingham · P30 · FY2015 · AI

Women's Interagency HIV Study (WIHS) IV

$3,257,199
Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny) · U01 · FY2008 · AI

Reagent Program for HIV and other Infectious Diseases

$3,250,651
Sujatha Rashid · American Type Culture Collection · N01 · FY2021 · AI

CHEM-1005: Development of Human-Relevant Small Animal Models of Sulfur Mustard Toxicities

$3,250,000
Office Of The Director, National Institutes Of Health · Y01 · FY2020 · OD

Terry Beirn CPCRA Clinical Trials Unit

$3,249,978
Fred M Gordin · George Washington University · UM1 · FY2014 · AI

Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU

$3,249,397
Daniel R Kuritzkes · Massachusetts General Hospital · U01 · FY2011 · AI

Reagent Program for HIV and other Infectious Diseases

$3,248,336
Sujatha Rashid · American Type Culture Collection · N01 · FY2022 · AI

Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)

$3,248,075
Kenneth E Palmer · University Of Louisville · U19 · FY2016 · AI

Use Of Animal Models To Study Lipid Genes That Modulate Atherosclerosis

$3,245,489
Alan Remaley · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL